Hippocrates has entered into a strategic partnership with Antin Infrastructure Partners to enhance its growth and service capabilities within the Italian pharmacy sector.
Target Information
Hippocrates is the premier independent pharmacy platform in Italy, boasting a network of over 120 pharmacies across northern and central regions. Established in March 2018 by co-CEOs Davide Tavaniello and Rodolfo Guarino, Hippocrates is positioned to capitalize on significant growth opportunities within the proximity healthcare sector. Both co-founders will reinvest in the business and maintain their roles as co-CEOs, ensuring continuity of leadership.
With Antin Infrastructure Partners' support, Hippocrates is set to embark on a new developmental phase, aimed at expanding its network and delivering exceptional service to patients, ultimately striving to become the leading provider of proximity healthcare in Italy.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview
The healthcare industry in Italy has experienced significant transformations in recent years, driven by an increasing demand for accessible and personalized care services. The pharmacy secto
Similar Deals
NTC s.r.l. → Formycon’s Eylea® biosimilar FYB203/Baiama®
2025
Boston Scientific → Nalu Medical
2026
Barça Innovation Hub → Omniscope
2025
Antin Infrastructure Partners
invested in
Hippocrates
in 2021
in a Strategic Partnership deal